-
Salinosporamide A (Marizomib) is a
potent proteasome inhibitor being studied as a
potential anticancer agent. It
entered phase I
human clinical trials...
- prepared.
Salinosporamide A
Salinosporamide B
Salinosporamide C
Salinosporamide D
Salinosporamide E
Salinosporamide F
Salinosporamide G
Salinosporamide H Salinosporamide...
-
Longifolene Ginkgolides A and B
Lactacystin Miroestrol Ecteinascidin 743
Salinosporamide A
Corey and his
research group created LHASA, a
program that uses artificial...
-
obligate marine actinomycete bacterium species. It
produces salinosporamide A and
salinosporamide B,
potential anti-cancer agents, as well as the polycyclic...
-
reaction was used to
construct key
cyclic intermediates for
syntheses of
salinosporamide A, diversonol, and anatoxin-a. Many
reviews have been written, including:...
-
cyclohexenone moiety. They were the
second group of
compounds (after
salinosporamide A)
isolated from Salinispora, and were said to
indicate the potential...
-
several recently developed chemotherapy agents such as
bortezomib and
salinosporamide A. In
response to
cellular stresses – such as infection, heat shock...
- E)
Glycoprotein NMB and
Microtubules 1/3
Cancer Phase I
Marizomib (
Salinosporamide A) N/A
Bacterium Beta-Lactone-Gamma
Lactam 20S
Proteasome 4/4 Cancer...
- is an
obligate marine actinomycete bacterium species. It
produces salinosporamide, a
potential anti-cancer agent.
Salinispora tropica Salinispora pacifica...
-
isolated from
Salinospora tropica, from the
biosynthetic pathway of
salinosporamide A. The
fluorinase catalyses an SN2-type
nucleophilic substitution at...
